From Barrier to Breakthrough Scalable HSC-to-NK Manufacturing

On-Demand Webinar | From Barrier to Breakthrough: Scalable HSC-to-NK Manufacturing

Discover how you can build a feeder-free, scalable workflow using data-driven development. This webinar introduces an approach that eases compliance pressures while improving control, efficiency, and manufacturability.

Join ImmuneBridge and Sartorius as we share the story behind a transformation that broke through long standing barriers in immune cell manufacturing. You’ll get an inside look into how a close customer–-supplier collaboration helped move from early, limiting methods to a more scalable, controlled manufacturing strategy. Faced with real-world constraints, the teams challenged conventional thinking, reimagined development, and found new ways to break through long-standing barriers.

If you’re navigating similar challenges in cell therapy development, this session offers a real-world example of how collaboration and scientific rigor can turn obstacles into opportunity.

What You Will Learn:

Learn how stirred-tank bioreactors enable controlled and scalable HSC-NK bioprocessing.
Discover how DOE-driven optimization improves HSC-NK expansion and differentiation.
See how GMP-grade raw materials enhance consistency and manufacturing.

Clear form data

Please Complete the Form

First Name *

Last Name *

Email *

Phone Number *

Company *

Job Title *

Address *

Country *

Postal Code *

I would like to sign up for newsletters from Sartorius (Sartorius AG and its affiliated companies) based of my personal interests.
I can revoke my consent at any time with effect for the future by sending an e-mail to unsubscribe@sartorius.com or by clicking on the "unsubscribe" link in e-mails I have received.

* These fields are required Information on the use of your data can be found in our privacy policy

Complete Form to Watch

Rukmini Ladi

Segment Technology Manager, Cell Therapy, Advanced Therapies Solutions

Rukmini Ladi is a Segment Technology Manager for Cell Therapy at Sartorius with more than ten years of experience in cell and gene therapy process development. She supports global cell therapy developers in designing end-to-end, scalable workflows.

She specializes in designing and optimizing immune and stem cell therapy workflows for translational and manufacturing applications.

Rui Tostoes, PhD

Chief Technical Officer, ImmuneBridge

Rui Tostoes is an accomplished scientist and creative leader, with a passion for product and people development in cell therapy and bioprocessing. Through his work in MilliporeSigma and FloDesign Sonics, he is experienced in matrix work with functional areas of R&D, product development, and commercial in delivering successful product development and customer program execution.